Ligand Pharmaceuticals

LGND | NASDAQ

Price Alert Chart Builder DCF Calculator

$292.72

+$2.65 (+0.91%)

Sep 22, 2026, 11:26 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	124.45M	-4.03M	52.15M	-33.36M	57.14M	-2.99M
Depreciation & Amortization	35.72M	35.24M	36.52M	51.37M	50.95M	27.97M
Stock-Based Compensation	n/a	41.09M	25.74M	60.29M	38.78M	30.73M
Other Working Capital	-1.8M	16.2M	-16.23M	1.64M	-21.96M	35.04M
Other Non-Cash Items	-120.83M	21.2M	-42.14M	-26.84M	-7.29M	28M
Deferred Income Tax	22.68M	-15.8M	11.7M	20.72M	-8.62M	-19.05M
Change in Working Capital	-12.67M	19.36M	-34.4M	65.68M	-52.16M	-10.06M
Operating Cash Flow	49.36M	97.05M	49.58M	137.85M	78.8M	54.59M
Capital Expenditures	-452K	-19.64M	-53.85M	-17.92M	-8.76M	-4.46M
Cash Acquisitions	-8.09M	-172.19M	-25.65M	-750K	494K	-383.32M
Purchase of Investments	-730.86M	-226.38M	-126.76M	-51.23M	-181.33M	-422.52M
Sales Maturities Of Investments	377.28M	269.62M	194.17M	234.39M	221.34M	1.04B
Other Investing Acitivies	-4.34M	-12.89M	-49.91M	-868K	-1.22M	3.26M
Investing Cash Flow	-377.32M	-143.66M	-11.68M	163.62M	30.52M	231.65M
Debt Repayment	338.11M	-25K	-76.9M	-260.8M	-146.01M	-231.76M
Common Stock Repurchased	-15M	n/a	n/a	n/a	-18.45M	-78M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-9.77M	60.03M	-5.5M	-18.42M	-7.07M	-789K
Financial Cash Flow	428.22M	97.14M	-59.95M	-275.99M	-137.76M	-310.55M
Net Cash Flow	102.62M	49.35M	-22.05M	25.48M	-28.44M	-24.31M
Free Cash Flow	48.91M	77.41M	-4.27M	119.93M	70.04M	50.13M
Adj. Free Cash Flow	48.91M	36.32M	-30.02M	59.64M	31.25M	19.4M
Maintenance CapEx	n/a	-14.85M	-53.85M	-17.92M	-1.72M	-1.31M
Growth CapEx	-452K	-4.79M	n/a	n/a	-7.04M	-3.15M
Owner Earnings	49.36M	82.2M	-4.27M	119.93M	77.07M	53.28M